Pharmacotherapy follow-up of key points in the safety of oral antineoplastic agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacotherapy follow-up of key points in the safety of oral antineoplastic agents

Published:2016-02-12 Issue:3 Volume:26 Page:e12463
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

Escudero-Vilaplana V.¹,Ribed A.¹,Romero-Jimenez R.M.¹,Herranz-Alonso A.¹,Sanjurjo-Saez M.¹

Affiliation:

1. Pharmacy Department; Gregorio Marañón University General Hospital; Madrid Spain

Funder

Instituto de Salud Carlos III

European Regional Development Fund

Una Manera de hacer Europa

Publisher

Wiley

Subject

Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ecc.12463/fullpdf

Reference30 articles.

1. Overview of the changing paradigm in cancer treatment: oral chemotherapy;Aisner;American Journal of Health-System Pharmacy,2007

2. Potential drug interactions and side effects in an outpatient oncology clinic: a retrospective descriptive study;Bayraktar-Ekincioglu;European Journal of Hospital Pharmacy,2014

3. Characteristics of potential drug-related problems among oncology patients;Bulsink;International Journal of Clinical Pharmacy,2013

4. Managing side effects of tyrosine kinase inhibitor therapy to optimize adherence in patients with chronic myeloid leukemia: the role of the midlevel practitioner;Cornelison;Journal of Supportive Oncology,2012

5. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;European Journal of Cancer,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program;The Oncologist;2024-09-14

2. Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report;Medicina;2024-06-25

3. Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy;Frontiers in Oncology;2023-08-25

4. A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital;Frontiers in Public Health;2022-11-04

5. Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis;European Journal of Cancer Care;2022-10-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3